All National Institute for Health and Care Excellence (NICE) articles – Page 21
-
News
Outside groups could vie with NICE over guidance
Professional organisations and interest groups could take on a formal role producing clinical commissioning guidance - potentially sidestepping the National Institute for Health and Clinical Excellence.
-
News
Lib Dems call for better access to psychological therapy
The Liberal Democrats have called for the improved access to psychological therapy programme to be extended beyond 2014 and to be included in the NHS Outcomes Framework.
-
News
Board mandate may be shortened
The government is preparing to significantly shorten and simplify its mandate to the NHS Commissioning Board, HSJ has learned. It comes in the wake of widespread criticism of the draft version.
-
News
Revealed: extent of harm to patients under NHS care
More than 20 per cent of patients suffer avoidable harm during their care at some trusts, a national survey of frontline NHS services has revealed.
-
News
New rules to tackle drugs lottery
More details have come to light of how hospitals that delay acting on National Institute for Health and Clinical Excellence guidance will be forced to explain hold-ups to patients.
-
News
Hospitals criticised over baby infection delays
Some hospitals are causing “unnecessary delays” in treating newborn babies suffering from infections, the healthcare watchdog has said.
-
Comment
Uniting voices in epilepsy treatment
Patients and clinicians can lead in standard and availability of neurosurgical options
-
News
Nicholson orders trusts to offer approved drugs
All NHS organisations have been ordered to publish details of which drugs they will routinely fund in a bid to make sure patients get medicines they are legally entitled to.
-
News
NICE proposes indicators for holding CCGs to account
The National Institute for Health and Clinical Excellence has suggested 44 indicators which could be used to monitor the success of clinical commissioning groups.
-
HSJ Knowledge
Patients 'should take trusts to court' over drug access
‘Numerous trusts are acting unlawfully… denying patients an innovative and cost-effective treatment,’ writes NICE chair Sir Michael Rawlins in a recent HSJ article. Read the article, listen to the BBC’s follow-up and share your views.
-
Comment
Michael Rawlins: playing fair on treatments
A few weeks ago, Steve Winyard, head of policy and campaigns at the Royal National Institute of Blind People (RNIB), asked to see me.
-
HSJ Knowledge
How GPs can remove obstacles to QIPP targets
Delivering the QIPP targets is proving a tough challenge for GP practices. Paul Cook offers some practical ideas on how to remove the obstacles in the way.
-
News
NICE: trusts must offer DVT tests within 24 hours
Hospitals have been set “challenging” new clinical targets to provide a “seven-days-a-week” service for patients presenting with a suspected venous thromboembolism.
-
Comment
Commissioning outcomes framework will enable meaningful quality improvement
The framework will help organisations prioritise performance issues.
-
News
Lansley confirms NICE will no longer take funding decisions
The National Institute for Health and Clinical Excellence will no longer directly decide whether the NHS funds a drug under the proposed new pricing system, health secretary Andrew Lansley has confirmed.
-
News
Drug costs 'have to be secret' under new pricing system
Drug prices agreed under the government’s proposed new pricing system would have to remain secret if drug companies are to buy into it, a senior figure in the pharmaceutical industry has warned.
-
News
Mike Rawlins: NICE drug judgements can be improved
Judgements on which drugs should be paid for by the NHS can be improved, the chair of the National Institute for Health and Clinical Excellence has said.
-
Comment
Michael White: driving down the cost of drug deals
The NHS should have little sympathy for Big Pharma.
-
HSJ Local
TIA clinic leads the way for Nottingham
STRUCTURE: Nottingham University Hospitals NHS Trust has become one the first hospitals in the country to set up a dedicated nurse-led clinic to care for patients who have had a minor stroke or transient ischaemic attack (TIA).
-
News
Value-based pricing 'will not improve' cancer drug access
Government proposals to introduce a value-based pricing system for new drugs will not significantly improve patient access to treatments, experts have warned.